PSYCHOTROPIC SOLUTIONS

Similar documents
PSYCHOTROPIC SOLUTIONS

Behavioral and Psychological Symptoms of dementia (BPSD)

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

Delirium. Quick reference guide. Issue date: July Diagnosis, prevention and management

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document.

Behavioural Symptoms of Dementia

Antipsychotic Medications

Psychotropic Medication. Including Role of Gradual Dose Reductions

Managing Behavioural Problems in Patients with Learning Disabilities

Appendix 2017UEMS031

A publication of Alzheimer s Queensland.

Communication with Cognitively Impaired Clients For CNAs

Community Pharmacy Dementia Audit

CEPP National Audit Antipsychotics in Dementia

BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA

Workshop cases answers

9/11/2012. Clare I. Hays, MD, CMD

Identifying, Diagnosing and Managing Dementia

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches

FOR RESIDENTIAL FACILITIES

Wicking Dementia Research & Education Centre, University of Tasmania, 2017

Prescribing for people with dementia. Carol Paton Chief Pharmacist April 2009

How to prevent delirium in nursing home. Dr. Sophie ALLEPAERTS Geriatric department CHU-Liège Belgium

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

National Audit of Dementia

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Optimising antipsychotic medication management for responsive behaviour. Review. Plan. Withdraw. Quick Reference Cards. Prescribe

-Guidelines for the discontinuation of oral antipsychotics in patients with BPSD within the primary care setting Summary- Quetiapine

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

12/17/2012. Unnecessary Drugs

OBJECTIVES. Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia

Supporting people with dementia to live well in London care homes

Dementia Care Principles

Older People Mental Health - new directorate/new plans. Dr Adrian Treloar Clinical director

Guideline for the Identification and Management of Delirium (Including use of the THINK DELIRIUM Support Tool)

Professor Tony Holland, Department of Psychiatry, University of Cambridge

DEMENTIA AND MEDICATION

Addressing Difficult Behaviors in Dementia

Improving the quality of care of patients with delirium

Behavioural and Psychological Symptoms and Medications Presentation

Delirium. Delirium. Delirium Etiology and Pathophysiology. Fall 2018

New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm. Presenters.

Table to Demonstrate a method of working through Triggered CAPs.

Dementia: Reducing use of antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) National & London Context

Do you need specialist palliative care skills to support people with Dementia at the end of their lives?

Caring for a Patient or Family Member with Alzheimer s Disease or Related Dementia

Northumbria Healthcare NHS Foundation Trust. Your guide to understanding Delirium. Issued by Department of Medicine

From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018

DELIRIUM. Approach and Management

Dementia Behaviour Management Advisory Services (DBMAS)

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics

Psychotropic Strategies Handout Package

2010 National Audit of Dementia (Care in General Hospitals) Guy's and St Thomas' NHS Foundation Trust

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

Drugs used to relieve behavioural and psychological symptoms in dementia

DELIRIUM DR S A R A H A B D E L A T I S A S DR H I L A R Y W O L F E N D A L E S T 4

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

Delirium. Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta

Submission on the Draft National Clinical Practice Guidelines for Dementia in Australia

Behavioral Interventions

Antidepressants for treatment of depression.

The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Symptom Management Pocket Guides: DELIRIUM

Pain: Facility Assessment Checklists

Delirium Information for patients and relatives. Delirium is common Delirium is treatable Relatives can stay to help us

Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care

Managing agitation in dementia using non-pharmacological therapies

PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES

145 overall responses (30 Respondents did not complete the survey after Q3 (no data))

Medicine Related Falls Risk Assessment Tool (MRFRAT)

Assessment and early identification

Understanding the impact of pain and dementia

Relationship Between Mental Health Problems and Challenging Behaviour in People with Intellectual Disabilities

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use

Antipsychotic Medication in Dementia; The good, the bad and the ugly! Anthony Bainbridge Deputy Director of Nursing Sheffield Health and Social Care

Charles Bernick, MD, MPH Cleveland Clinic Lou Ruvo Center for Brain Health June 2, 2018

Risks of Antipsychotics use In Dementia

Psychotropic Drug Therapy in Adults with Learning Disability. Steve Wilkinson

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

2010 National Audit of Dementia (Care in General Hospitals) Chelsea and Westminster Hospital NHS Foundation Trust

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services

Delirium Information for relatives, carers and patients

Vanderbilt & Qsource Webinar Series

Integrating INTERACT into Interim Pharmacist Reviews

The Place for Treatments of Associated Neuropsychiatric and Other Symptoms in Alzheimer s Disease and Other Dementias

Triage in Aged Persons Mental Health. David McMillan Clinical Nurse Consultant Caulfield Hospital Alfred Health

2010 National Audit of Dementia (Care in General Hospitals) North West London Hospitals NHS Trust

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018

Benzodiazepines: risks, benefits or dependence

Managing Challenging Behaviour in Dementia Care

Centre for Research on Ageing [influencing policy improving practice enhancing quality of life]

The Agitated. Older Patient: old. What To Do? Michelle Gibson, MD, CCFP Presented at Brockville General Hospital Rounds, May 2003

Reshaping Care Pathways for Older People. Anne Hendry National Clinical Lead for Quality

Management of Behavioral Problems in Dementia

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative

Optimising treatment and care for people with behavioural and psychological symptoms of dementia

Transcription:

PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Key Senate Committee Recommendations: All RACF employees should receive accredited training in the management of BPSD Antipsychotic medications should be reviewed by the GP after the first 3-months Accreditation audits should report on general antipsychotic usage patterns in each facility Develop guidelines for the recording and reporting on all forms of restraint. This material is for the exclusive use of contracted Choice Aged Care clients 1

Review of National Aged Care Quality Regulatory Processes (extracts): The Oakden Review Use a star-rated system for public reporting of provider performance For Example: measurement of the proportion of residents taking more than 5 medications who receive RMMRs Aged care standards will limit the use of restrictive practices: Accreditation assessments will review the use of psychotropic agents An RACF s antipsychotic rate will be publicly reported RMMRs must be conducted for residents on admission to an aged care service, after any hospitalisation, upon deterioration of behaviour or any change in the medication regime. The lack of informed consent in current practice contributes to the high levels of antipsychotic use The elimination of restrictive practices is a goal that both government and providers should aspire to. This material is for the exclusive use of contracted Choice Aged Care clients 2

PERSON CENTRED CARE can be an effective alternative to antipsychotics. Identify any unmet needs. Care is designed to meet the resident s unique needs with goals based on their values and experiences. The resident s physical, psychological and social goals have been considered and prioritised. SYMPTOMS that may warrant the use of an Antipsychotic are limited to: Aggression causing severe distress or an immediate risk of harm. Psychotic symptoms causing severe distress or an immediate risk of harm. Wandering or calling behaviours are UNLIKELY to respond to an Antipsychotic (except via side effects). YOU. YOU. YOU YOU accept your ongoing role and responsibility within the health team. YOU accept the resident s history and commit to person centred principles. YOU accept the role and skills of others within the multidisciplinary health team This material is for the exclusive use of contracted Choice Aged Care clients 3

CONSENT has been obtained correctly from the resident or their representative and documented. Understand and adhere to the facility s policy on psychotropic consent. Consents should specify the diagnosis and target symptoms; desired outcomes; the drug and dose to be used; potential side effects; expected duration of treatment and review frequency. HEALTH CARE TEAM involvement. The complexity of dementia requires a coordinated multidisciplinary team approach. Referral to a Geriatrician; Clinical Pharmacist via an RMMR; DBMAS; SBRT and allied health services have been considered. OFFER the GP a Changed Circumstances RMMR referral and input from external services Medication reviews (RMMR) by Choice Aged Care consultants have been found to reduce antipsychotic usage. A key recommendation from the Oakden Review was that RMMRs must be conducted for residents on admission to an aged care service, after any hospitalisation, upon deterioration of behaviour or any change in the medication regime. External dementia services also exist. This material is for the exclusive use of contracted Choice Aged Care clients 4

TREAT the underlying cause Assess for and treat physical illness including: delirium; pain; infections; constipation; medication toxicity; sleep deprivation; thirst or hunger; blood test abnormalities (i.e. B12, folate, thyroid, biochemistry). Assess for and treat psychosocial factors (change of routine; loss of independence; new carers etc ) Assess and treat psychiatric disorders which may mimic or exacerbate BPSD (e.g. depression, anxiety, PTSD). RESTRAINT (chemical and physical) should only be used as a last resort to prevent harm The reason for the use of restraint and psychotropics should be documented and reviewed regularly. Restraint is only appropriate when there is severe threat to the resident s own safety, other residents or staff. Should only be a temporary solution; in the least restrictive form; and with appropriate consent. ORGANISATIONAL commitment to: Person centred care and dementia friendly environments Nurse and carer training and competency in the psychosocial and psychotropic management of BPSD. Monitor antipsychotic drug usage levels and trends A Medication Management policy that appropriately outlines protocols relating to high risk medications. This material is for the exclusive use of contracted Choice Aged Care clients 5

Selected QUM risk medications Risperidone Facility average (%) Corporate average (%) Choice Aged Care average (%) Comments & Recommendations Olanzapine Quetiapine Amitriptyline Temazepam Diazepam Oxazepam PSYCHOSOCIAL and non pharmacological strategies are prioritised and considered first line. Utilise a person centred approach to the resident s individuality. Creative and flexible application of non drug approaches which may include music therapy; massage; aromatherapy; environmental changes; exercise; pet therapy etc... IDENTIFY influences and triggers for the behaviours that challenge. BPSD may have a range of physical, environmental and psychosocial causes. The Need Driven Behaviour model suggests unmet needs manifest in behaviours. The Progressively Lowered Threshold model attributes BPSD to a progressive inability to manage stress. This material is for the exclusive use of contracted Choice Aged Care clients 6

CARE and support for the resident s family and care staff Relationship centred care emphasises the imperative to consider the needs, provide support and enhance the involvement of care staff and family. Person centred care may require family and care staff education, support and contribution to care. START LOW & GO SLOW with increased vigilance for side effects. Starting doses should be low, increasing slowly as necessary, with careful monitoring for adverse effects. Frequent GP and nursing staff reviews early in the course of therapy are essential. Response to antipsychotics usually occurs within 1 2 weeks and well within 12 weeks. This material is for the exclusive use of contracted Choice Aged Care clients 7

ONGOING NEED REVIEWED REGULARLY to confirm therapy is still appropriate There should be no longer than a 6 weeks interval between GP reviews of a resident taking an antipsychotic. A GP review on the antipsychotic s actual ongoing need should be conducted at least every 3 months. Behaviours may abate with time as dementia progresses or if the initial BPSD was due to an acute cause. LOWEST EFFECTIVE DOSE Pursue the lowest possible dose of the antipsychotic to achieve the therapeutic effect. The elderly generally require lower medication dosages. UTILISE QUM (safe, effective, appropriate & judicious use of antipsychotics) Follow for quality use of antipsychotics. Intervention with an antipsychotic may aim to settle distress, though they should not compromise clarity of consciousness or quality of life. This material is for the exclusive use of contracted Choice Aged Care clients 8

TIME LIMITTED & TRIAL WITHDRAWALS When antipsychotics are needed, they should initially be considered as a trial for a specified period. Discontinue treatment if there is no improvement in the target behaviour. Several studies report no worsening of behaviour when antipsychotic therapy for BPSD is withdrawn. INEFFECTIVE? (do any benefits outweigh the risks?) Antipsychotics have at best a small positive effect on behaviour. If the psychotropic is found to be ineffective, it should be altered or withdrawn. Some behaviours respond poorly to antipsychotics e.g. shouting, wandering (walking), insomnia; inappropriate voiding. ORGANISATIONAL COMMITMENT Maximise the input of external dementia services and Choice Aged Care s clinical RMMR pharmacist. Develop appropriate medication policy and procedures with respect to antipsychotics (e.g. consent and restraint protocols; drug usage and trend monitoring; protocols for antipsychotic use ). Ensure all staff involved in care have competency in psychotropic and psychosocial therapies. Promote person-centred care approaches and utilise dementia friendly design principles. This material is for the exclusive use of contracted Choice Aged Care clients 9

NON DRUG OPTIONS should continue to be maximised for residents on an antipsychotic. Continue to pursue creative and individually tailored approaches based on the resident s unique needs. Options include: music therapy; massage; aromatherapy; exercise; pet therapy; gardening; environmental changes; carer education; reassurance; distraction; activities etc... SIDE EFFECTS? (are side effects/risks outweighed by any benefits?) Antipsychotics increase the risk of death (via strokes, pneumonia and heart arrhythmia). Antipsychotics can also cause sedation, confusion, fracture, falls, Parkinsonism and affect mobility & swallow. Polypharmacy increases the risk of side effects. THANKYOU & ANY QUESTIONS? Michael Bonner CEO, Clinical Pharmacist Choice Aged Care PH: 1300 276 087 E: michael@choiceagedcare.com.au www.choiceagedcare.com.au This material is for the exclusive use of contracted Choice Aged Care clients 10